Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.10.2023 | Case report

Brentuximab-vedotin

Pityriasis lichenoides et varioliformis acuta-like eruption: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Iinuma S, et al. Pityriasis lichenoides et varioliformis acuta-like eruption after brentuximab vedotin treatment for peripheral T-cell lymphoma. European Journal of Dermatology 33: 316-317, No. 3, May-Jun 2023. Available from: URL: https://www.springer.com/journal/40699 Iinuma S, et al. Pityriasis lichenoides et varioliformis acuta-like eruption after brentuximab vedotin treatment for peripheral T-cell lymphoma. European Journal of Dermatology 33: 316-317, No. 3, May-Jun 2023. Available from: URL: https://​www.​springer.​com/​journal/​40699
Metadaten
Titel
Brentuximab-vedotin
Pityriasis lichenoides et varioliformis acuta-like eruption: case report
Publikationsdatum
01.10.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-47470-z

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Lanreotide